| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $782.5M | +18.5% |
| R&D Expense | $60.5M | +55.0% |
| SG&A Expense | $3.5M | +34.6% |
| Operating Income | $213.4M | +8.0% |
| Pre-tax Income | $157.6M | +56.0% |
| Income Tax | $37.1M | +171.5% |
| Net Income | $120.5M | -21.2% |
| EPS (Basic) | $1.33 | -22.2% |
| EPS (Diluted) | $1.24 | -19.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $293.4M | -2.9% |
| Accounts Receivable | $118.9M | +13.4% |
| Inventory | $58.4M | +99.6% |
| Current Assets | $773.2M | +39.9% |
| Total Assets | $1.92B | +17.3% |
| Current Liabilities | $691.3M | +46.5% |
| Long-term Debt | $978.0M | -0.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $272.6M | -30.4% |
| Investing Cash Flow | -$179.3M | -18.1% |
| Financing Cash Flow | -$100.6M | +46.6% |
| Total Liabilities |
| $1.70B |
| +16.4% |
| Stockholders' Equity | $217.6M | +24.7% |